retatrutide phase 2 results obesity nejm 2023

retatrutide phase 2 results obesity nejm 2023 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending 🧬 R3TA is a next-generation

Name: retatrutide phase 2 results obesity nejm 2023 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending 🧬 R3TA is a next-generation
Brand: gerloff.com
SKU: 24807187293
Price: 23.04 USD
Availability: InStock
Rating: 4.5418 (13 reviews)

SKU: 24807187293

4.5

USD23.04 USD45.04

Pay in 4 interest-free payments of $5.76 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

"The flooding situation is a disaster

In men, excess adipose tissue promotes the conversion of testosterone into estrogen

K., Aktas, A., et al

Further studies include REDEFINE 3 (heart benefits vs placebo in adults with heart disease) and REDEFINE 4 (84-week head-to-head vs tirzepatide 15 mg)